![]() |
|||
|
|
|
|
| UPDATE: June 1996 | MW: 520.66 | MF: C22H34N2O6•H2O4S |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 500 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
TJADAB 38,15,1988
|
oral | mouse
lowest published toxic dose: 5 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
TJADAB 38,15,1988
|
oral | mouse
lowest published toxic dose: 150 mg/kg (11-13 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TJADAB 38,15,1988
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraduodenal | rat
lethal dose (50 percent kill): 2,230 mg/kg
|
N/R
|
AIPTAK 180,155,1969
|
intravenous | mouse
lethal dose (50 percent kill): 114 mg/kg
|
Eye: Other eye effects | Lung, Thorax, or Respiration: Cyanosis Gastrointestinal: Changes in structure or function of salivary glands
ARZNAD 11,521,1961
|
oral | mouse
lethal dose (50 percent kill): 4,800 mg/kg
|
Eye: Other eye effects | Lung, Thorax, or Respiration: Cyanosis Gastrointestinal: Changes in structure or function of salivary glands
ARZNAD 11,521,1961
|
oral | rat
lethal dose (50 percent kill): 5,538 mg/kg
|
N/R
|
TXAPA9 18,185,1971
|
subcutaneous | mouse
lethal dose (50 percent kill): 290 mg/kg
|
Eye: Other eye effects | Lung, Thorax, or Respiration: Cyanosis Gastrointestinal: Changes in structure or function of salivary glands
ARZNAD 11,521,1961
|
subcutaneous | rat
lethal dose (50 percent kill): >4 gm/kg
|
N/R
|
AIPTAK 180,155,1969
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X3133 |
Number of Industries 1; Total Number of Facilities 1,204; Number of Occupations 7; Total Number of Employees Exposed 23,118; Total Number of Female Employees Exposed 9,688 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
| |